Clinical Outcomes of COVID-19 in Hematological Malignancies in Jordan : Tertiary Cancer Center Experience

Introduction: The COVID-19 infection has a devastating clinical outcome among individuals with immunocompromised states, particularly those with malignancies. The impact of the coronavirus pandemic on patients with hematological malignancies in low and middle-income countries is not well studied. He...

Descripción completa

Detalles Bibliográficos
Autores principales: Ababneh, Hazim, Alqadi, Fadwa, ma'Akoseh, Mohammad, Halahleh, Khalid, abo Abed, Layan, Akkawi, Mohammad, Al-Rabi, Kamal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology. Published by Elsevier Inc. 2021
Materias:
906.Outcomes Research-Myeloid Malignancies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701602/
http://dx.doi.org/10.1182/blood-2021-154509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701602/
http://dx.doi.org/10.1182/blood-2021-154509

Ejemplares similares